NATIONAL TAIWAN UNIVERSITY HOSPITAL
πΉπΌTaiwan
- Country
- πΉπΌTaiwan
- Ownership
- Private
- Established
- 1895-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.ntuh.gov.tw
A Randomized Study to Evaluate the Efficacy of Herbal Ingredients Combined With a Carrier System (Phytonail) Compared With Amorolfine 5% Nail Lacquer (Loceryl) in the Treatment of Toenail Onychomycosis
- First Posted Date
- 2013-08-27
- Last Posted Date
- 2013-08-27
- Lead Sponsor
- National Taiwan University Hospital
- Target Recruit Count
- 72
- Registration Number
- NCT01929187
- Locations
- π¨π³
National Taiwan University Hospital, Taipei, Taiwan
18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.
- Conditions
- Breast Cancer18F-FDG PET
- First Posted Date
- 2013-08-23
- Last Posted Date
- 2014-04-15
- Lead Sponsor
- National Taiwan University Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT01927939
- Locations
- π¨π³
National Taiwan University Hospital, Taipei, Taiwan
Using "PET Response Criteria in Solid Tumors (PERCIST)" in Evaluating Response to Neoadjuvant Chemoradiotherpy for Esophageal Cancer
- Conditions
- Esophageal Cancer
- First Posted Date
- 2013-08-23
- Last Posted Date
- 2014-04-15
- Lead Sponsor
- National Taiwan University Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT01927978
- Locations
- π¨π³
National Taiwan University Hospital, Taipei, Taiwan
Study on the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family.
- Conditions
- Head-and-Neck Squamous Cell Carcinoma
- First Posted Date
- 2013-08-22
- Last Posted Date
- 2013-09-16
- Lead Sponsor
- National Taiwan University Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT01927354
- Locations
- π¨π³
National Taiwan University Hospital research Ethics Committee, Taipei, Taiwan
The Effectiveness of Smoking Cessation in Prediabetic Smokers
Not Applicable
Active, not recruiting
- Conditions
- Diabetes MellitusCigarette SmokingPrediabetes
- Interventions
- Drug: Varenicline for tobacco smoking cessationBehavioral: Individualized counseling about both smoking cessation and weight control techniques
- First Posted Date
- 2013-08-20
- Last Posted Date
- 2024-04-30
- Lead Sponsor
- National Taiwan University Hospital
- Target Recruit Count
- 589
- Registration Number
- NCT01926041
- Locations
- π¨π³
National Taiwan University Hospital and its Yunlin branch, Taipei, Department Of Family Medicine, Taiwan
Pseudomonal Type Three Secretion System and Contact Lens Associated Microbial Keratitis
- Conditions
- Keratitis; Infectious Disease (Manifestation)
- First Posted Date
- 2013-08-20
- Last Posted Date
- 2014-04-15
- Lead Sponsor
- National Taiwan University Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT01925846
- Locations
- π¨π³
Department of Ophthlamology, National Taiwan University Hospital, Taipei, Taiwan
Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B
Phase 4
- Conditions
- Chronic Hepatitis B
- Interventions
- Drug: Pegasys&Entecavir
- First Posted Date
- 2013-08-20
- Last Posted Date
- 2014-12-04
- Lead Sponsor
- National Taiwan University Hospital
- Target Recruit Count
- 540
- Registration Number
- NCT01925820
- Locations
- π¨π³
National Taiwan University Hospital Department of Internal Medicine, Taipei, Taiwan
Thoracic Fluid Content and Acute Lung Injury
Completed
- Conditions
- Acute Lung Injury
- Interventions
- Device: NICOM
- First Posted Date
- 2013-08-14
- Last Posted Date
- 2013-08-14
- Lead Sponsor
- National Taiwan University Hospital
- Target Recruit Count
- 22
- Registration Number
- NCT01922557
- Locations
- π¨π³
Department of Anesthesiology, NTUH, Taipei, Taiwan
AUY922 in Patient With Stage IV NSCLC
- First Posted Date
- 2013-08-14
- Last Posted Date
- 2018-07-18
- Lead Sponsor
- National Taiwan University Hospital
- Target Recruit Count
- 31
- Registration Number
- NCT01922583
- Locations
- π¨π³
Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
π¨π³National Cheng Kung University Hospital, Tainan, Taiwan
π¨π³Taipei Veterans General Hospital, Taipei, Taiwan
Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy
Not Applicable
Completed
- Conditions
- Proliferative Diabetic Retinopathy
- Interventions
- Drug: intravitreal injection of 1.25 mg of bevacizumab
- First Posted Date
- 2013-08-13
- Last Posted Date
- 2013-08-13
- Lead Sponsor
- National Taiwan University Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT01920984
- Locations
- π¨π³
Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan
Β© Copyright 2025. All Rights Reserved by MedPath